Icon
+91 94997 68112
Login Register

Avandamet - (500mg; EQ 1,2,4mg Base: 1gm; EQ 2,4mg BASE, Tablet)

Rosiglitazone Maleate and Metformin Hydrochloride SB PHARMCO
500mg; EQ 1,2,4mg Base: 1gm; EQ 2,4mg BASE, Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
Indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus for whom all other oral antidiabetic agents, in monotherapy or in combination, do not result in adequate glycemic control or are inappropriate
Yes
**** ** *** ***** ** **** *** **** ** *** *** **** ** *** ******* **** *** ********* ******* * **********. ********* ** *** ***** ** ********** **** *** ***** *** ** ****** **** *** ******* ******** ** *******, ********* *** ********* **** ******* **** ** *** ***** ******* ****. ***** ***** ** *** ********** ****** ************.
Avandamet Patent 1 Patent 2
**** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ *** **** **** ******* ******** ************ *** ** ******
  1. ***, **** : *** ***** * **** ******* **** ** **** *** ***** * ****** *** ********** **** ******* ******* & *******.
  2. ***, **** : *** ******* * ********** **** **** ********* ** *** ***** ** ***** **** *** ***** *** ** ****** **** *** ******* ******** ** *******, ********* *** ********* **** ******* **** ** *** ***** ******* ****.***** ***** ** *** ********** ****** ************.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.